1[1]Simons FER,Simons KJ. Clinical pharmacology of new histamine H1 antagonists[J]. Clin Pharmacokinet, 1999, 36: 329.
2[2]Yumibe N, Huie K, Chen KJ, et al. Identification of human liver cytochrome P450 enzymes that metabolizethe nonsedating antihistamine loratadine. Formation ofdescarboethoxyloratadine by CYP3A4 and CYP2D6[J].Biochem Pharmacol, 1996, 51:165.
3[3]Handley DA, Mccullough JR, Fang Y, et al. Descarboet-hoxyloratadine, a metabolite of loratadine, is a superiorantihistamine[J]. Ann Allergy Asthma Immunol, 1997,78(1):164.
4[4]Anthes JC, Richard C, West RE, et al. Functional char-acterization of desloratadine and other antihistaminesin a Chinese hamster ovary(CHO)cell line that expressthe cloned human histamine H1 receptor and in humanbronchial smooth muscle cells(HBSNC)[J] .J AllergyClin Immunol, 2000, 105(1, Part 2): 1 125.
5[5]Agrawal DK.Antiinflammator properties of deslorata-dine (DCL) :Effects on eosinophil chemotaxis, adhesionand release of superoxide anions[J].J Allergy Clin Im-munol, 2000, 105(1, Part 2): 49.
6[6]Berthon B, Taudou G, Combettes L, et al. In vitro in-hibition, by loratadine and descarboethoxyloratadine, ofhistamine release from human basophils, and of histam-ine release and intracellular calcium fluxes in rat baso-philic leukemia cells (RBL-2H3)[J] .Biochem Phar-macol, 1994, 47: 789.
7[7]Vignola AM, Crampette L, Mondain M, et al. Inhibito-ry activity of loratadine and descarboethoxyloratadineon expression of ICAM-1 and HLA-DR by nasal ep-ithelial cells[J]. Biochem Pharmacol, 1995, 52:200.
8[8]Kreumer W, Hey JA, Anthes J, et al. Preclinical effica-cy and antiallergic profile of desloratadine, a selectiveand nonsedating histamine H1 receptor antagonist[J].J Allergy Clin Immunol, 2000, 105(1, Part 2): 1 118.
9[9]Padhi D,Banfield C,Gupta S,et al. Multiple-dose pha-rmacokinetics, safety, and tolerance of desloratadine inhealthy volunteers[J] .J Allergy Ciin lmmunol, 2000,105(1, Part 2): 1 124.
10[10]Herron JM,Padhi D,Affrime MB, et al. Dose-proport-ionality, linearity, and pharmacokinetics of desloratadi-ne in healthy adults[J]. J Allergy Clin Immunol, 2000,105(1,Part 2):1 126.
